Advertisement
Screener

CORCEPT THERAPEUTICS INC (CORT) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

CORCEPT THERAPEUTICS INC Stock-Based Compensation

CORCEPT THERAPEUTICS INC (CORT) reported Stock-Based Compensation of $52.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-07-29

  • CORCEPT THERAPEUTICS INC share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $29.42M, a 54.63% increase year-over-year.
  • CORCEPT THERAPEUTICS INC share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $23.04M, a 5.56% increase year-over-year.
  • CORCEPT THERAPEUTICS INC share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $20.77M, a 23.65% increase year-over-year.
  • CORCEPT THERAPEUTICS INC share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $22.88M, a 42.09% increase year-over-year.
  • CORCEPT THERAPEUTICS INC share-based payment arrangement, noncash expense for fiscal 2025 was $84.50M, a 37.73% increase from fiscal 2024.
  • CORCEPT THERAPEUTICS INC share-based payment arrangement, noncash expense for fiscal 2024 was $61.35M, a 25.37% increase from fiscal 2023.
  • CORCEPT THERAPEUTICS INC share-based payment arrangement, noncash expense for fiscal 2023 was $48.94M, a 15.31% increase from fiscal 2022.
  • CORCEPT THERAPEUTICS INC share-based payment arrangement, noncash expense for fiscal 2022 was $42.44M, a 1.14% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 158 monthShare-based Payment Arrangement, Noncash Expense 161 monthShare-based Payment Arrangement, Noncash Expense 164 monthShare-based Payment Arrangement, Noncash Expense 167 month
2026-06-30$29.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$52.46M
10-Q · filed 2026-07-29
$73.23M
derived: sum of 3 quarters · filed 2026-07-29
$96.11M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$23.04M
10-Q · filed 2026-04-30
$43.81M
derived: sum of 2 quarters · filed 2026-04-30
$66.69M
derived: sum of 3 quarters · filed 2026-04-30
$85.71M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$20.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$43.65M
derived: sum of 2 quarters · filed 2026-02-24
$62.67M
derived: sum of 3 quarters · filed 2026-07-29
$84.50M
10-K · filed 2026-02-24
2025-09-30$22.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$41.90M
derived: sum of 2 quarters · filed 2026-07-29
$63.73M
10-Q · filed 2025-11-04
$80.53M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$19.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$40.85M
10-Q · filed 2026-07-29
$57.65M
derived: sum of 3 quarters · filed 2026-07-29
$73.75M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$21.83M
10-Q · filed 2026-04-30
$38.63M
derived: sum of 2 quarters · filed 2026-04-30
$54.73M
derived: sum of 3 quarters · filed 2026-04-30
$69.94M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$16.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$32.90M
derived: sum of 2 quarters · filed 2026-02-24
$48.10M
derived: sum of 3 quarters · filed 2026-02-24
$61.35M
10-K · filed 2026-02-24
2024-09-30$16.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$31.31M
derived: sum of 2 quarters · filed 2025-11-04
$44.56M
10-Q · filed 2025-11-04
$57.62M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$15.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$28.46M
10-Q · filed 2025-07-31
$41.52M
derived: sum of 3 quarters · filed 2026-02-24
$54.40M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$13.25M
10-Q · filed 2025-05-05
$26.31M
derived: sum of 2 quarters · filed 2026-02-24
$39.19M
derived: sum of 3 quarters · filed 2026-02-24
$51.05M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$13.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$25.94M
derived: sum of 2 quarters · filed 2026-02-24
$37.80M
derived: sum of 3 quarters · filed 2026-02-24
$48.94M
10-K · filed 2026-02-24
2023-09-30$12.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
$24.73M
derived: sum of 2 quarters · filed 2024-10-30
$35.88M
10-Q · filed 2024-10-30
$46.40M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$11.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29
$23.00M
10-Q · filed 2024-07-29
$33.52M
derived: sum of 3 quarters · filed 2025-02-26
$44.07M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$11.14M
10-Q · filed 2024-05-01
$21.66M
derived: sum of 2 quarters · filed 2025-02-26
$32.22M
derived: sum of 3 quarters · filed 2025-02-26
$42.82M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$10.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$21.07M
derived: sum of 2 quarters · filed 2025-02-26
$31.68M
derived: sum of 3 quarters · filed 2025-02-26
$42.44M
10-K · filed 2025-02-26
2022-09-30$10.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$21.16M
derived: sum of 2 quarters · filed 2023-11-01
$31.92M
10-Q · filed 2023-11-01
$42.73M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30$10.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$21.37M
10-Q · filed 2023-08-02
$32.18M
derived: sum of 3 quarters · filed 2024-02-15
$43.13M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31$10.76M
10-Q · filed 2023-05-03
$21.57M
derived: sum of 2 quarters · filed 2024-02-15
$32.52M
derived: sum of 3 quarters · filed 2024-02-15
$43.59M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31$10.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
$21.76M
derived: sum of 2 quarters · filed 2024-02-15
$32.83M
derived: sum of 3 quarters · filed 2024-02-15
$42.93M
10-K · filed 2024-02-15
2021-09-30$10.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$22.02M
derived: sum of 2 quarters · filed 2022-11-03
$32.12M
10-Q · filed 2022-11-03
$40.55M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$11.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$21.17M
10-Q · filed 2022-08-04
$29.60M
derived: sum of 3 quarters · filed 2023-02-28
$38.30M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$10.10M
10-Q · filed 2022-05-05
$18.53M
derived: sum of 2 quarters · filed 2023-02-28
$27.23M
derived: sum of 3 quarters · filed 2023-02-28
$35.72M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$8.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$17.13M
derived: sum of 2 quarters · filed 2023-02-28
$25.62M
derived: sum of 3 quarters · filed 2023-02-28
$33.54M
10-K · filed 2023-02-28
2020-09-30$8.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$17.19M
derived: sum of 2 quarters · filed 2021-11-03
$25.11M
10-Q · filed 2021-11-03
$32.72M
derived: sum of 4 quarters · filed 2022-02-15
2020-06-30$8.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
$16.41M
10-Q · filed 2021-07-29
$24.02M
derived: sum of 3 quarters · filed 2022-02-15
$31.29M
derived: sum of 4 quarters · filed 2022-02-15
2020-03-31$7.92M
10-Q · filed 2021-05-06
$15.53M
derived: sum of 2 quarters · filed 2022-02-15
$22.80M
derived: sum of 3 quarters · filed 2022-02-15
$30.54M
derived: sum of 4 quarters · filed 2022-02-15
2019-12-31$7.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15
$14.88M
derived: sum of 2 quarters · filed 2022-02-15
$22.62M
derived: sum of 3 quarters · filed 2022-02-15
$29.31M
10-K · filed 2022-02-15
2019-09-30$7.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03
$15.01M
derived: sum of 2 quarters · filed 2020-11-03
$21.70M
10-Q · filed 2020-11-03
$27.97M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30$7.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$14.43M
10-Q · filed 2020-08-04
$20.70M
derived: sum of 3 quarters · filed 2021-02-23
$27.21M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$6.70M
10-Q · filed 2020-05-04
$12.96M
derived: sum of 2 quarters · filed 2021-02-23
$19.47M
derived: sum of 3 quarters · filed 2021-02-23
$25.49M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31$6.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
$12.78M
derived: sum of 2 quarters · filed 2021-02-23
$18.79M
derived: sum of 3 quarters · filed 2021-02-23
$23.75M
10-K · filed 2021-02-23
2018-09-30$6.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$12.53M
derived: sum of 2 quarters · filed 2019-11-07
$17.48M
10-Q · filed 2019-11-07
$21.31M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30$6.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$10.97M
10-Q · filed 2019-08-01
$14.80M
derived: sum of 3 quarters · filed 2020-02-24
$18.43M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31$4.95M
10-Q · filed 2019-05-09
$8.79M
derived: sum of 2 quarters · filed 2020-02-24
$12.41M
derived: sum of 3 quarters · filed 2020-02-24
$15.61M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31$3.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$7.46M
derived: sum of 2 quarters · filed 2020-02-24
$10.66M
derived: sum of 3 quarters · filed 2020-02-24
$13.36M
10-K · filed 2020-02-24
2017-09-30$3.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$6.83M
derived: sum of 2 quarters · filed 2018-11-02
$9.53M
10-Q · filed 2018-11-02
$11.49M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$3.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$5.91M
10-Q · filed 2018-08-09
$7.86M
derived: sum of 3 quarters · filed 2019-02-26
$9.69M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$2.70M
10-Q · filed 2018-05-09
$4.66M
derived: sum of 2 quarters · filed 2019-02-26
$6.49M
derived: sum of 3 quarters · filed 2019-02-26
$8.15M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$1.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$3.79M
derived: sum of 2 quarters · filed 2019-02-26
$5.45M
derived: sum of 3 quarters · filed 2019-02-26
$7.06M
10-K · filed 2019-02-26
2016-09-30$1.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$3.49M
derived: sum of 2 quarters · filed 2017-11-03
$5.10M
10-Q · filed 2017-11-03
$6.59M
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$3.27M
10-Q · filed 2017-08-02
$4.76M
derived: sum of 3 quarters · filed 2018-02-28
$6.31M
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$1.61M
10-Q · filed 2017-05-02
$3.11M
derived: sum of 2 quarters · filed 2018-02-28
$4.65M
derived: sum of 3 quarters · filed 2018-02-28
$6.22M
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$3.04M
derived: sum of 2 quarters · filed 2018-02-28
$4.60M
derived: sum of 3 quarters · filed 2018-02-28
$6.01M
10-K · filed 2018-02-28
2015-09-30$1.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$3.11M
derived: sum of 2 quarters · filed 2016-11-02
$4.52M
10-Q · filed 2016-11-02
$5.91M
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30$1.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$2.98M
10-Q · filed 2016-08-03
$4.36M
derived: sum of 3 quarters · filed 2017-03-06
$5.58M
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31$1.41M
10-Q · filed 2016-05-04
$2.80M
derived: sum of 2 quarters · filed 2017-03-06
$4.01M
derived: sum of 3 quarters · filed 2017-03-06
$5.23M
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31$1.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
$2.60M
derived: sum of 2 quarters · filed 2017-03-06
$3.82M
derived: sum of 3 quarters · filed 2017-03-06
$5.20M
10-K · filed 2017-03-06
2014-09-30$1.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$2.44M
derived: sum of 2 quarters · filed 2015-11-06
$3.81M
10-Q · filed 2015-11-06
$5.13M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$1.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$2.60M
10-Q · filed 2015-08-07
$3.92M
derived: sum of 3 quarters · filed 2016-03-10
$5.22M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31$1.38M
10-Q · filed 2015-05-08
$2.69M
derived: sum of 2 quarters · filed 2016-03-10
$4.00M
derived: sum of 3 quarters · filed 2016-03-10
$5.26M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$2.62M
derived: sum of 2 quarters · filed 2016-03-10
$3.89M
derived: sum of 3 quarters · filed 2016-03-10
$5.20M
10-K · filed 2016-03-10
2013-09-30$1.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$2.57M
derived: sum of 2 quarters · filed 2014-11-07
$3.88M
10-Q · filed 2014-11-07
$4.93M
derived: sum of 4 quarters · filed 2015-03-13
2013-06-30$1.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$2.58M
10-Q · filed 2014-08-08
$3.62M
derived: sum of 3 quarters · filed 2015-03-13
$4.61M
derived: sum of 4 quarters · filed 2015-03-13
2013-03-31$1.31M
10-Q · filed 2014-05-12
$2.36M
derived: sum of 2 quarters · filed 2015-03-13
$3.35M
derived: sum of 3 quarters · filed 2015-03-13
$4.23M
derived: sum of 4 quarters · filed 2015-03-13
2012-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13
$2.04M
derived: sum of 2 quarters · filed 2015-03-13
$2.92M
derived: sum of 3 quarters · filed 2015-03-13
$5.31M
10-K · filed 2015-03-13
2012-09-30$993.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$1.88M
derived: sum of 2 quarters · filed 2013-11-12
$4.26M
10-Q · filed 2013-11-12
$5.30M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$883.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$3.27M
10-Q · filed 2013-08-09
$4.30M
derived: sum of 3 quarters · filed 2014-03-14
$5.26M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$2.39M
10-Q · filed 2013-05-08
$3.42M
derived: sum of 2 quarters · filed 2014-03-14
$4.37M
derived: sum of 3 quarters · filed 2014-03-14
$5.24M
derived: sum of 4 quarters · filed 2014-03-14
$22.40M
10-Q · filed 2012-05-10
2011-12-31$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
$1.99M
derived: sum of 2 quarters · filed 2014-03-14
$2.85M
derived: sum of 3 quarters · filed 2014-03-14
$3.44M
10-K · filed 2014-03-14
$20.01M
10-K · filed 2012-03-13
2011-09-30$954.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$1.82M
derived: sum of 2 quarters · filed 2012-11-08
$2.40M
10-Q · filed 2012-11-08
$2.99M
derived: sum of 4 quarters · filed 2013-03-15
$18.98M
10-Q · filed 2011-11-08
2011-06-30$869.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$1.45M
10-Q · filed 2012-08-09
$2.03M
derived: sum of 3 quarters · filed 2013-03-15
$2.58M
derived: sum of 4 quarters · filed 2013-03-15
$18.03M
10-Q · filed 2011-08-09
2011-03-31$580.00K
10-Q · filed 2012-05-10
$1.17M
derived: sum of 2 quarters · filed 2013-03-15
$1.71M
derived: sum of 3 quarters · filed 2013-03-15
2010-12-31$585.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$1.13M
derived: sum of 2 quarters · filed 2013-03-15
$2.12M
10-K · filed 2013-03-15
2010-09-30$545.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$1.53M
10-Q · filed 2011-11-08
2010-06-30$986.00K
10-Q · filed 2011-08-09
2009-12-31$1.80M
10-K · filed 2012-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52